Psoriasis: clinical review
Content developed by MIMS Learning http://www.mimslearning.co.uk/
Psoriasis affects around 2% of the adult population, and while the main manifestation is dermatological, it is associated with various systemic comorbidities, including cardiovascular disease, metabolic syndrome, non-alcoholic fatty liver disease, diabetes, Crohn's disease, depression and cancer, all of which add to the disease burden
Psoriasis is a stigmatising condition and is associated with anxiety, reduced quality of life and significant psychosocial disability. Its impact on quality of life is comparable to that for other chronic conditions, including IHD and COPD.
This resource covers the identification of the clinical type and severity of psoriasis to enable tailored treatment to be planned. Key learning points include clinical findings, differentiating atypical psoriasis from other skin diseases, and prognosis.
After completing this module, you should be better able to:
Dr David J Chandler, Clinical research fellow in dermatology, Weatherall Institute of Molecular Medicine, University of Oxford; and Dr Anthony Bewley, Consultant dermatologist, Barts Health NHS Trust, London. Updated by the authors in 2016.
This resource is provided at an advanced level by MIMS Learning. Read the article and reflect on what you have learned, then answer the test questions at the end.
Complete the resource to obtain a certificate of completion to include in your revalidation portfolio. You should record the time spent on this resource in your CPD log.